RZRuiyao Zhao

Ruiyao Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ruiyao Zhao has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Jianwei Wu

    Department of Urology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People’s Republic of China

    2 shared publications
  • Wenyu Sun

    Department of Urology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People’s Republic of China

    2 shared publications
  • Wenzhong Zheng

    Department of Urology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People’s Republic of China

    1 shared publication
  • Wenzhong Zheng

    Department of Urology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of China

    1 shared publication
  • Xu Yang

    Department of Urology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of China

    1 shared publication
  • Yan Yan

    Department of Nephrology, Xianyou County General Hospital, Xianyou, Fujian, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Global, Regional, and National Burden of Female Infertility Attributable to Chlamydia Infections, 1990–2023: An Analysis Based on the Global Burden of Disease Study 2023

    by Wenyu Sun, Yan Yan, Jianwei Wu, Ruiyao Zhao, Wenzhong Zheng

    Background: Chlamydia infection, the most common bacterial sexually transmitted infection worldwide, frequently leads to tubal infertility. With the rising global prevalence of female infertility, the World Health Organization has highlighted untreated sexually transmitted infections as a preventable cause. Chlamydia has been identified as a leading contributor to infertility attributable to sexually transmitted infections; however, comprehensive and up-to-date estimates specifically focused on chlamydia-attributable female infertility remain limited. This study aimed to quantify the global, regional, and national burden of female infertility due to chlamydia infection from 1990 to 2023. Methods: Data on the prevalence and years lived with disability (YLD) due to chlamydia-induced female infertility in women aged 15– 49 years were sourced directly from the Global Burden of Disease Study 2023. Estimates for the number of cases, age-standardized prevalence rate(ASPR), age-standardized YLD, average annual percentage changes (AAPCs)in both prevalence and YLD were calculated globally, regionally, and nationally, stratified by age, and Socio-demographic Index (SDI). Results: Between 1990 and 2023, the global prevalence of female infertility attributable to chlamydia infection surged, with cases rising from 2.76 million to 4.76 million. Moreover, infertility attributed to chlamydia infections was most frequently observed among women aged 40 to 44 years (ASPR 342.04/100,000, 95% UI[287.27-402.88]). The ASPR of female infertility caused by chlamydia was markedly higher in low and low-middle SDI regions compared with other SDI regions. The middle SDI region experienced the greatest increase in ASPR (AAPC 0.61, 95% CI[0.59 - 0.63]). Regionally, Western Sub-Saharan Africa reported the highest ASPR and age-standardized YLD rate for chlamydia-induced infertility. At the national level, Cabo Verde had the highest ASPR and age-standardized YLD rate for this condition. Brazil demonstrated the most rapid growth in ASPR and YLD for infertility from 1990 to 2023. These burden estimates were positively but weakly correlated with the SDI level (all P < 0.05). Conclusion: From 1990 to 2023, the global prevalence of female infertility attributable to chlamydia infection increased. The highest ASPR was observed among women aged 40– 44 years, and the burden was disproportionately higher in low and low-middle SDI regions. These findings highlight the need to expand routine chlamydia screening and treatment services, particularly in Western Sub-Saharan Africa and countries such as Brazil, to curb the rising burden of chlamydia-induced infertility.

  • Open Access

    Global Prevalence of Infertility Attributable to Sex Chromosome Abnormalities: Insights from the Global Burden of Disease Study

    by Ruiyao Zhao, Wenyu Sun, Xu Yang, Jianwei Wu, Yongsheng Li, Wenzhong Zheng

    Background: Klinefelter syndrome (KS) and Turner syndrome (TS) are chromosomal disorders characterized by gonadal dysgenesis, leading to male and female infertility, respectively. There is a significant gap in epidemiological data on infertility related to hereditary gonadal dysgenesis due to sex chromosomal abnormalities in individuals aged 15– 49. Methods: A systematic analysis was conducted to examine the prevalence and Years Lived with Disability (YLD) due to infertility linked to KS and TS across 21 regions and 204 countries from 1990 to 2021. Estimates for cases, age-standardized prevalence rates (ASPR), age-standardized YLDs, and average annual percentage changes (AAPCs) in prevalence and YLDs were calculated, stratified by age and socio-demographic index (SDI). Results: The global burden of infertility due to gonadal dysgenesis shows significant gender and regional disparities. The prevalence of male infertility linked to KS gradually increased (ASPR rose from 11 to 12/100,000, AAPC=0.09, P< 0.05) between 1990 and 2021, with the highest rates in Western and Eastern Europe (ASPR 19– 20/100,000) and the fastest growth in East Asia (AAPC=0.44, P< 0.05). In contrast, the prevalence of female infertility associated with TS slightly declined globally (ASPR decreased from 6.55 to 6.3/100,000, AAPC=− 0.12, P< 0.05), particularly in North America and Western Europe. Although absolute YLDs increased due to population growth, age-standardized rates remained stable, indicating no significant worsening of health impacts. Conclusion: From 1990 to 2021, male infertility from KS increased gradually, while female infertility due to TS decreased slightly. There’s an urgent need for better prepubertal identification, fertility preservation, and tailored screening, especially in Europe, East Asia, and North America. Data scarcity in low-SDI regions may distort infertility trend.